Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
54,711,345
-
Total 13F shares
-
34,562,212
-
Share change
-
+1,074,725
-
Total reported value
-
$791,472,895
-
Price per share
-
$22.90
-
Number of holders
-
67
-
Value change
-
+$23,374,012
-
Number of buys
-
40
-
Number of sells
-
24
Institutional Holders of Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) as of Q1 2020
As of 31 Mar 2020,
Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,562,212 shares.
The largest 10 holders included
Apple Tree Partners IV, L.P., RTW INVESTMENTS, LP, Redmile Group, LLC, Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., FEDERATED HERMES, INC., VANGUARD GROUP INC, and PERCEPTIVE ADVISORS LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.